1. |
SVANVIK T, MARCICKIEWICZ J, SUNDFELDT K, et al. Sociodemographic disparities in stage-specific incidences of endometrial cancer:a registry-based study in West Sweden,1995-2016[J]. Acta Oncol, 2019, 58(6):845-851.
DOI
URL
|
2. |
马丽娜, 孙笑, 王丽华. 1型胰岛素样生长因子受体和表皮生长因子受体在子宫内膜癌中的临床价值[J]. 检验医学, 2019, 34(10):918-922.
|
3. |
SHANG C, AO C N, CHEONG C C, et al. Long non-coding RNA CDKN2B antisense RNA 1 gene contributes to paclitaxel resistance in endometrial carcinoma[J]. Front Oncol, 2019, 9:27.
DOI
PMID
|
4. |
郭珍珍, 尹瑞雪, 田小飞. miRNA与女性生殖系统肿瘤的研究进展[J]. 世界最新医学信息文摘, 2019, 19(76):123-125.
|
5. |
隋守光, 赵素伟, 路建宽, 等. 肝癌组织中miR-433表达及其对多西他赛化疗耐药的机制研究[J]. 中国临床药理学杂志, 2020, 36(11):1507-1510.
|
6. |
WERNER H M, TROVIK J, MARCICKIEWICZ J, et al. Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification[J]. Gynecol Oncol, 2012, 125(1):103-108.
DOI
PMID
|
7. |
THERASSE P, ARBUCK S G, EISENHAUER E A, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000, 92(3):205-216.
DOI
URL
|
8. |
WESTIN S N, FELLMAN B, SUN C C, et al. Prospective phase Ⅱ trial of levonorgestrel intrauterine device:nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer[J]. Am J Obstet Gynecol, 2021, 224(2):191.e1-191.e15.
|
9. |
游兴文, 管华平, 王艳虹, 等. 放化疗联合应用对高危子宫内膜癌患者血清肿瘤标志物水平及预后的影响[J]. 癌症进展, 2020, 18(1):48-50.
|
10. |
CASTELLANO T, JOHN MAXWELL I V, ADAM WALTER J, et al. Phase Ⅱ trial of vaginal cuff brachytherapy followed by dose-dense chemotherapy in early stage endometrial cancer patients with enriched,high-intermediate risk factors for recurrence[J]. Gynecol Oncol, 2021, 160(3):669-673.
DOI
URL
|
11. |
SUN R, LIU J, NIE S, et al. Construction of miRNA-mRNA regulatory network and prognostic signature in endometrial cancer[J]. Onco Targets Ther, 2021, 14:2363-2378.
DOI
URL
|
12. |
WANG Q, XU K, TONG Y, et al. Novel miRNA markers for the diagnosis and prognosis of endometrial cancer[J]. J Cell Mol Med, 2020, 24(8):4533-4546.
DOI
PMID
|
13. |
黄蓉, 王云飞, 杨飞, 等. MicroRNA在子宫内膜癌中的调控作用[J]. 世界最新医学信息文摘, 2020, 20(19):2.
|
14. |
胡晓磊, 黄萍妹, 王洁, 等. MiR433靶向调控Notch1逆转人乳腺癌细胞对多西他赛的耐药性[J]. 南方医科大学学报, 2018, 38(7):888-894.
|
15. |
JIN L, ZHANG N, ZHANG Q, et al. Serum microRNAs as potential new biomarkers for cisplatin resistance in gastric cancer patients[J]. PeerJ, 2020, 8:e8943.
DOI
URL
|